Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Joint Pain Injections Market?

The market size for joint pain injections has seen rapid growth in recent years. This market is expected to increase from $6.12 billion in 2025 to $6.89 billion in 2026, at a compound annual growth rate (CAGR) of 12.5%. The historical growth can be attributed to several factors including the rising prevalence of arthritis and joint disorders, an aging global population, increasing demand for minimally invasive pain treatments, growing awareness of regenerative therapies, and the expansion of orthopedic specialty care.

The joint pain injections market size is projected to undergo rapid expansion in the coming years. It is foreseen to grow to $10.96 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.3%. The anticipated growth during this period is attributable to the increasing adoption of biologic pain therapies, a rising focus on personalized medicine, the expansion of sports injury management, growing investments in regenerative medicine, and an increasing preference for non-opioid pain management. Key trends observed in the forecast period include the increasing adoption of non-surgical pain management therapies, the rising use of hyaluronic acid and PRP injections, a growing demand for personalized pain treatment approaches, the expansion of regenerative medicine-based injections, and an enhanced focus on outpatient pain relief solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

Which Drivers Are Supporting The Rise Of The Joint Pain Injections Market?

The expanding occurrence of arthritis and musculoskeletal conditions is expected to boost the demand for the joint pain injections market. Globally, musculoskeletal disorders represent the primary source of disability, with low back pain standing out as the foremost cause of impairment across 160 nations. Individuals frequently receive injections to alleviate pain and manage inflammatory conditions. As an illustration, in August 2023, the Institute for Health Metrics and Evaluation (IHME), an independent U.S.-based health research organization, published findings indicating that approximately 1 billion people are anticipated to suffer from osteoarthritis by 2050. Consequently, the increasing incidence of arthritis and musculoskeletal disorders is a significant factor propelling the joint pain injections market.

What Leading Segments Are Studied In The Joint Pain Injections Market?

The joint pain injections market covered in this report is segmented –

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections

2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types

3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies

Subsegments:

1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections

2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections

What Industry Trends Are Transforming The Joint Pain Injections Market?

Major companies involved in joint pain injections are concentrating on developing innovations, such as single-injection formulations, which prioritize convenience for patients. A single-injection formulation describes a drug delivery system intended to administer a precise medication dose in a single shot, delivering sustained therapeutic effects over an extended duration without the need for multiple doses. For example, in July 2024, LG Chem Ltd., a South Korea-based chemicals company, introduced Synovian in China, a new treatment for knee osteoarthritis featuring a convenient single-injection formulation, making it the first of its kind in the country. The product seeks to enter a significant market valued at approximately KRW 200 billion (around USD 150 million). Developed using proprietary technology, it demonstrates innovation in addressing patient requirements, focusing on providing effective relief with minimal administration hassle.

Which Major Industry Participants Are Leading The Joint Pain Injections Market Growth?

Major companies operating in the joint pain injections market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus Inc., Flexion Therapeutics Inc., Ferring Pharmaceuticals Inc., Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited, AstraZeneca plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Which Region Is Projected To Lead The Joint Pain Injections Market During The Forecast Period?

North America was the largest region in the joint pain injections market in 2025. The regions covered in the joint pain injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Joint Pain Injections Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6482&type=smp

Browse Through More Reports Similar to the Global Joint Pain Injections Market 2026, By The Business Research Company

Pain Management Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Bone And Joint Health Supplements Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bone-and-joint-health-supplements-global-market-report

Non Opioid Pain Patch Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company